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Abstract
Background: Since most clinical guidelines address single diseases, treatment of patients with multimorbidity, the
co-occurrence of multiple (chronic) diseases within one person, can become complicated. Information on highly
prevalent combinations of diseases can set the agenda for guideline development on multimorbidity. With this
systematic review we aim to describe the prevalence of disease combinations (i.e. disease clusters) in older patients
with multimorbidity, as assessed in available studies. In addition, we intend to acquire information that can be
supportive in the process of multimorbidity guideline development.
Methods: We searched MEDLINE, Embase and the Cochrane Library for all types of studies published between
January 2000 and September 2012. We included empirical studies focused on multimorbidity or comorbidity that
reported prevalence rates of combinations of two or more diseases.
Results: Our search yielded 3070 potentially eligible articles, of which 19 articles, representing 23 observational
studies, turned out to meet all our quality and inclusion criteria after full text review. These studies provided
prevalence rates of 165 combinations of two diseases (i.e. disease pairs). Twenty disease pairs, concerning 12
different diseases, were described in at least 3 studies. Depression was found to be the disease that was most
commonly clustered, and was paired with 8 different diseases, in the available studies. Hypertension and diabetes
mellitus were found to be the second most clustered diseases, both with 6 different diseases. Prevalence rates for
each disease combination varied considerably per study, but were highest for the pairs that included hypertension,
coronary artery disease, and diabetes mellitus.
Conclusions: Twenty disease pairs were assessed most frequently in patients with multimorbidity. These disease
combinations could serve as a first priority setting towards the development of multimorbidity guidelines, starting with
the diseases with the highest observed prevalence rates and those with potential interacting treatment plans.
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Introduction
The growing interest in the concept of multimorbidity, which
refers to the co-occurrence of multiple (often chronic) diseases
or medical conditions within one person[1], is motivated by the
rising prevalence of multimorbidity, its negative health
consequences, and the challenge to manage multimorbid
patients in health care settings, often family medicine
practice[2-11].
Managing patients with multimorbidity is much more
complicated than managing patients with a single condition[10].
Clinical evidence-based guidelines have been developed to
provide recommendations for patient management, to define
standards of care, and focus efforts to improve quality.
However, most clinical guidelines address single diseases, and
do not always provide guidance for patients with multimorbidity.
Simply combining the current disease oriented guidelines might
result in a complex, inconvenient or even conflicting treatment
regime, in terms of interactions between drugs and diseases,
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conflicting management strategies, and polypharmacy[10-12].
To support health care providers in daily practice, guidelines for
combinations of diseases are thus warranted, especially for the
most prevalent combinations with complex or incompatible
regimes.
Despite the increasing body of research that has been
conducted in the field of multimorbidity, there is still no clear,
uniform operational definition for multimorbidity, and thus no
clear picture of common multimorbidity combinations. Over the
years, various methods have been developed and employed to
measure multimorbidity. There are indices available that
estimate a multimorbidity-score by weighting a range of
diseases (e.g. Charlson Comorbidity Index[13] or Cumulative
Illness Rating Scale[14]). Other applied multimorbidity
measures are the Chronic Disease Score[15], RxRisk
Model[16], or the Duke Severity of Illness Checklist[17].
Furthermore, multimorbidity can be assessed by simply
counting the number of co-existing diseases within a person,
using a predefined list of medical conditions. As disease counts
are easy to use, it is presumably the most common approach
to define multimorbidity.
Two recent systematic reviews described the available
measures of multimorbidity in more detail and pointed out that
the choice of a measure depends on the outcome of interest
and the type of data available[18,19]. Overall, these methods
are employed to predict health outcomes, for instance,
disability, quality of life, health care utilization or mortality.
Additionally, these methods are often applied to assess
prevalence rates. Prevalence estimates vary widely depending
on the study population, setting, data sources, the type of the
diseases considered and the number of conditions included in
the analysis[18,20-23].
Although evidence for the overall prevalence of
multimorbidity is accumulating, insight into the prevalence of
specific disease combinations (i.e. disease clusters) is limited.
A few studies explored disease clusters of multimorbidity by
conducting statistical cluster or factor analysis[24-26]. These
studies identified several broad clusters of diseases, but it
remained unclear which specific combinations of diseases
were most frequently occurring, taken into account the variation
in prevalence rates. To the best of our knowledge, there are no
systematic reviews that have investigated multimorbidity
clusters, and therefore, a complete overview is still lacking.
With this current systematic review we aim to describe the
prevalence of disease clusters in older patients with
multimorbidity, as found in published studies. In addition, we
intend to acquire information that can be supportive in the
process of developing multimorbidity guidelines that could
assist patient management and improve quality of health care.
Methods
Search strategy
To find eligible studies we consulted the electronic
databases MEDLINE/PubMed, Embase and Cochrane Library.
A search strategy was developed for each database, using a
combination of key words and Medical Subject Headings
(MEDLINE) or Emtree terms (EMBASE and Cochrane Library).
Since the term multimorbidity does not have an equivalent in
the database’s thesaurus, it was only searched as a key word.
Until recently, the term comorbidity was used interchangeably
with multimorbidity, as it also refers to the co-existence of
multiple conditions[1,27]. Hence, both terms and their spelling
variations were included in our search algorithm. We combined
search terms relating to multimorbidity (e.g. “multimorbid*”,
“multiple chronic diseas*”, “multiple illness*”), comorbidity,
chronic disease, and the definition or measurement (e.g.
“index”, “definition”, “measurement”, “list”, “instrument”). The
search strategy was developed iteratively to identify a
combination of terms with an acceptable level of sensitivity and
specificity. We restricted the search to articles with an available
abstract, published in English or Dutch, and those published
between January 2000 and September 2012. Before the year
2000, only a few articles had been published on the concept of
multimorbidity. We did not restrict the search to a specific study
type. To be complete, we also screened reference lists of all
included articles. The final search strategy for MEDLINE is
given in Appendix S1.
Study selection
The selection of studies followed several steps. First,
different inclusion and exclusion criteria were specified for the
selection of studies by title, abstract and full-text (Table 1).
Second, a random sample of fifteen titles was screened by two
authors (JS and JK) to control for unclear formulated inclusion
and exclusion criteria, before screening all titles of the yielded
articles; there was no disagreement or vagueness.
Subsequently, one author (JS) screened all titles for relevancy,
based on the defined inclusion and exclusion criteria (Table 1).
Third, two authors (JK and JS) independently appraised a
sample of twenty abstracts. There was no disagreement
between the two authors, after which all remaining abstracts
were screened for eligibility by one author (JS) and, when
necessary, by a second author (JK or JB). Last, full-text articles
were independently screened for eligibility by at least two
authors (JS screened all the full texts, and JK and JB both
screened half of the full texts). To evaluate the full text articles
on the inclusion and exclusion criteria, both authors appointed
to screen the full text article filled out a self-constructed
checklist. Discrepancies and ambiguities were solved by
discussion between the two authors and, when necessary, by a
third author.
Assessment of study quality
After titles and abstracts had been screened, all remaining
articles had an observational design. Therefore, quality
assessment of the articles was based on several items of the
Strengthening the Reporting of Observational studies in
Epidemiology (STROBE) checklist[28], which we included in
our checklist. The items that were required to be described in
the articles were (1) the study design; (2) the setting; (3) the
study size; (4) eligibility criteria of participants; (5) the type of
diseases included to measure comorbidity or multimorbidity; (6)
the data collection method; and (7) outcome data related to the
prevalence of combinations of diseases. These items, with
specific conditions, were also considered as inclusion and
Disease Clusters in Patients with Multimorbidity
PLOS ONE | www.plosone.org 2 November 2013 | Volume 8 | Issue 11 | e79641
exclusion criteria (see also Table 1). In addition, to be retained
in our review, only those articles that met our inclusion and
exclusion criteria, and thus our specified quality standard, were
selected.
Data extraction and synthesis
For each included study, the following data were extracted:
1 Study characteristics: First author, year of publication,
country, study size, setting, population age;
2 Information relating to the number and types of diseases
examined;
3 Information relating to (the prevalence of) the presented
disease clusters.
The checklist was employed to gather data about the study
characteristics. These data were tabulated and ordered
according to the population setting and the presence or
absence of a specific index-disease. A mean age was given or
calculated, but when impossible the age range was given.
Subsequently, all possible diseases, and disease combinations
as described in the included studies, were gathered, counted,
and tabulated. In addition, the accompanying prevalence rates
for each combination were collected and presented. When
necessary, odds ratios were converted into prevalence rates.
All given prevalence rates concerned the total study sample,
and if not, prevalence rates were converted to relate to the total
sample.
Results
Included studies
In total, 3070 potentially eligible articles were identified, of
which 2410 remained after exclusion of duplicates, see Figure
1. After screening of titles and abstracts, 279 articles remained
to be read completely. Of these articles, 212 were excluded
because they did not meet our inclusion criteria, as shown in
Figure 1. Additionally, 45 articles were found to be an abstract
or supplement for a congress and were excluded, 1 article was
excluded because of double publication of part of the results of
the same research project, and of 2 articles we had no access
to the full-text. As a result, 19 articles remained. One of these
articles focused on multimorbidity in different settings and
described the data of these populations separately. These
different settings were regarded as 5 individual studies and
therefore, our final sample for analysis represented 23 studies.
All 23 studies fulfilled our inclusion criteria and met our quality
criteria.
Study characteristics
All 23 studies had an observational design and were
conducted in either the general population (n =13)[23,29-38],
primary care (n =7)[23,39-43] or ambulatory care setting (n =1)
[44]. Two studies were based on data of the Veterans Health
Administration system (VHA)[6,45] (Table 2). The population
size of the studies varied from 599[23] to over one million[45]
individuals. Except for two[44,45], all studies reported clusters
of two diseases. In five studies[37,38,42,43,45] patients were
only included when diagnosed with a specific disease (i.e.
index-disease). In 8 studies[29,30,32-34,36,39,40] prevalence
rates were converted to provide comparable prevalence rates
of the disease clusters. In one study, odds ratios were
converted into prevalence rates[35].
Type of diseases
Sixty-three different diseases were found, of which some
were defined rather broadly (e.g. heart disease, gastrointestinal
Table 1. Inclusion and exclusion criteria of the screening process of the yielded articles.
Inclusion criteria Exclusion criteria
Titles - Included the words ‘multimorbidity’ or ‘comorbidity’ or related words(see step 1 and 2 in Appendix S2) - No data of disease combinations (or impossible to calculate prevalence rates)
 Titles not including these words were excluded - Age of at least half of the study population was ≤ 55 years
  - Diagnosis of a disease was based on medication prescription (ATC codes) only
Abstracts - Evidence that multimorbidity/comorbidity was the outcome variable, orthe central independent variable - Study size less than 500 persons
†
 - Availability of a list of diseases to account for multimorbidity/comorbidity, morbidity indices or measures. - Study conducted in a hospital setting
‡
 Abstracts not meeting these criteria were excluded. - Study examined solely two diseases§
  - Study was focused on an index-disease with a prevalence < 0.5% in the totalpopulation in the Netherlands
Full-texts - Availability of prevalence rates of specific disease clusters* - Study with a non-empiric research type: ‘letter’, ‘(narrative) review’, ‘editorial’, ‘case-study’, ‘presentation’, ‘commentary’
* or results that allowed the calculation of a prevalence rate: Some studies reported odds ratios instead of prevalence rates. These data were converted into prevalence
rates. If not possible, the article was excluded.
† to include studies with results based on solid, robust data
‡ our study is more focused on primary care as health professionals in primary care often see patients with multiple health conditions
§ we assumed that studies solely focusing on two diseases would provide insufficient disease clusters with applicable prevalence rates
doi: 10.1371/journal.pone.0079641.t001
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disease), while others were described in more detail (e.g.
cataract, atrial fibrillation). Diabetes mellitus was the most
frequently measured disease (described in 19 out of 23
studies). Other commonly assessed diseases were
hypertension, cancer, stroke, and depression (Figure 2).
Besides the 63 diseases, 165 combinations of two diseases
(i.e. disease pairs) and 50 combinations of three diseases (i.e.
disease triplets) were reported in the studies. Of the disease
pairs, 20 were described rather frequently (≥ 3 studies), see
Table 3. The disease triplets could not be replicated in any of
the other studies and were therefore not further analyzed.
The rank in frequency of diseases examined in the included
studies depended on the definition of the diseases. As
displayed in Figure 2, various diseases of the circulatory tract
were examined frequently (6 diseases in the top 20). However,
the definition of these diseases differed in level of detail. If
heart failure, coronary artery disease and heart attack/angina
were defined as heart disease (this broad definition could
comprise the separate diseases), heart disease was examined
in 17 studies instead of in 6 (in some studies coronary artery
disease and heart failure were both examined), making it the
third most commonly assessed disease. This also applied the
category COPD/asthma and the separate diseases asthma and
COPD. If the specific diseases were grouped into the broad
combined category, then COPD/asthma was investigated in 14
studies, instead of in 9 studies.
Disease clusters
The most frequently assessed combinations concerned 12
different diseases (Table 3). Regarding these diseases, several
clusters were identified. Of the assessed diseases, depression
was most frequently clustered, and was paired with 8 other
diseases. Additionally, hypertension and diabetes mellitus were
also found to be commonly clustered in the available studies
(with 6 different diseases). Although depression was the
disease most frequently assessed in pairs, the highest
prevalence rates were found for disease pairs including
hypertension, highest for its combination with osteoarthritis
(20%). The top ten disease combinations with the highest
prevalence rates all included the diseases hypertension,
coronary artery disease, and diabetes mellitus. In the studies
that focused on a specific index-disease, mainly studies
concerning depression, even higher prevalence rates were
identified; 57% of the patients with a major depression were
also diagnosed with hypertension (see Table 4).
Figure 1.  PRISMA Flow chart outlining the study selection process.  
doi: 10.1371/journal.pone.0079641.g001
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Per study, varying prevalence rates for each disease
combination were found. Especially for depression with
hypertension (from 1.2% to 12.9%), and for cancer with
hypertension (from 1.0% to 10.6%). Further, the highest
prevalence values were often found in studies in which the
morbidity data were collected via interviews or surveys. These
studies almost always concerned the general population.
Nearly all studies that applied electronic medical records
(EMRs) to collect morbidity data were executed in a primary
care setting.
Discussion
While multimorbidity in older people seems to be the rule
rather than the exception, evidence on the prevalence of
specific disease clusters in patients with multimorbidity is
limited. In this systematic review 19 articles were included,
representing 23 studies, that described 63 diseases and 165
disease pairs. Twenty disease pairs, comprising 12 different
diseases, were examined rather frequently. Of the assessed
diseases, depression was the disease most frequently
clustered, and was paired with 8 different diseases.
Hypertension and diabetes mellitus were found to be the
second most commonly clustered diseases, and were
combined with 6 different diseases. The combinations with the
highest prevalence rates included hypertension, coronary
artery disease and diabetes mellitus.
The prevalence estimates of disease clusters differed widely
among studies, a result that is in line with findings reported in
other reviews[20,46]. We will discuss two main possible
explanations. First, differences in the population under study
may affect the prevalence of multimorbidity and related disease
clusters, like age, income, or ethnicity[47-52]. Multimorbidity is
strongly associated with age[47-50]. Although we focused on
older adults, the population’s mean age still varied considerably
(from 56 years to 85 years). Further, multimorbidity seems
more common among people living in socioeconomically
deprived areas or people with a low income[47,49,50]. Second,
variation in prevalence rates might be due to the applied
definition of the diseases, the applied data collection method
and the study setting[18-21,53,54]. In our review, some
diseases were defined very broadly (e.g. cancer, heart
disease) while other diseases were defined in more detail (e.g.
osteoarthritis, atrial fibrillation). Studies executed in a primary
care setting often applied medical records with information on a
detailed level, yet they applied different classification codes
with different definitions or based on different diagnostic
methods (e.g. depression). In contrast, studies applied in the
general population often used surveys or interviews, all
inquiring about diseases differently. Other diseases, like
Figure 2.  Type of diseases examined in the included studies (top 20).  
doi: 10.1371/journal.pone.0079641.g002
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obesity, are not always considered as a disease and therefore
not included. As a consequence, few disease combinations
and accompanying prevalence rates were identical.
With our current results we have identified combinations of
diseases that are likely to co-occur and thus, a suitable
treatment plan needs to be developed. Existing clinical practice
guidelines, however, do not often address multimorbidity, and
following all guidelines for all individual diseases may lead to a
considerable treatment burden and to contradictory drug and
self-care regimes[10,11,55]. Indeed, Boyd et al.[10] reported
that several potential medication interactions were found for a
pattern that consisted of the diseases hypertension, diabetes
Table 3. Prevalence of clusters of two diseases.
Disease Clustered with
Prevalence per study (%; %; %), data gathered by
an   interview/survey*
Prevalence per study (%; %; %), data
collected by   patients’ EMRs* No. of study*
Depression Hypertension 1.2; 3.9; 7.6; 12.9  1, 12, 2, 8c
 Arthritis 1.7; 2.8; 4.9  1, 2, 12
 Diabetes Mellitus 1.7; 2.8 1.4 12, 2, 14
 COPD/Asthma 0.9; 1.8  2, 12
 Stroke 0.2; 0.9; 1.0 0.8; 1.1 1, 2, 12, 14, 3
 Cancer 1.1 0.9 12, 14
 Heart failure 0.7; 0.8 0.7 12, 2, 14
 Heart disease  0.6 1
Hypertension Osteoarthritis 18.7; 20.1 3.2; 4.1; 9.1 8c, 8a, 18, 8e, 8d
 Coronary artery disease 9.8; 14.9 7.6 7, 8a, 3
 Diabetes Mellitus 12.0; 14.0 2.5; 6.2; 6.4; 7.4 8b, 7, 3, 8e, 18, 8d
 Cancer 5.5; 10.6 1.0; 3.4 7, 8c, 18, 8e
 Depression 1.2; 3.9; 7.6; 12.9  1, 12, 2, 8c
 Dementia  2.9; 5.5 13, 3
Diabetes Mellitus Hypertension 12.0; 14.0 2.5; 6.2; 6.4; 7.4 8b, 7, 3, 8e, 18, 8d
 Coronary artery disease 4.1; 4.5 3.6 7, 6, 14
 Stroke 0.6; 2.9 1.9 4, 7, 14
 Depression 1.7; 2.8 1.4 12, 2, 14
 Heart failure 1.8 1.8; 2.2 6, 3,14
 Cancer 0.8; 2.2 1.9 4, 7, 14
Cancer Hypertension 5.5; 10.6 1.0; 3.4 7, 8c, 18, 8e
 Diabetes Mellitus 0.8; 2.2 1.9 4, 7, 14
 Depression 1.1 0.9 12, 14
 Stroke 0.5; 0.9 0.9 4, 7, 14
Stroke Diabetes Mellitus 0.6; 2.9 1.9 4, 7, 14
 Dementia  0.4; 2.7 13,3
 Depression 0.2; 0.9; 1.0 0.8; 1.1 1, 2, 12, 14, 3
 Cancer 0.5; 0.9 0.9 4, 7, 14
Coronary artery disease Hypertension 9.8; 14.9 7.6 7, 8a, 3
 Heart failure 2.8 2.8; 5.6 6, 14, 3
 Diabetes Mellitus 4.1; 4.5 3.6 7, 6, 14
Heart failure Coronary artery disease 2.8 2.8; 5.6 6, 14, 3
 Diabetes Mellitus 1.8 1.8; 2.2 6, 3,14
 Depression 0.7; 0.8 0.7 12, 2, 14
Dementia Hypertension  2.9; 5.5 13, 3
 Stroke  0.4; 2.7 13, 3
Osteoarthritis Hypertension 18.7; 20.1 3.2; 4.1; 9.1 8c, 8a, 18, 8e, 8d
Arthritis Depression 1.7; 2.8; 4.9  1, 2, 12
COPD/Asthma Depression 0.9; 1.8  2, 12
Heart disease Depression 0.6  1
Prevalence of disease clusters found in at least three studies
EMR: Electronic medical record
* Not bold: studies conducted in a primary care setting, bold: studies conducted in the general population, italic: study based on VHA (Veterans Health Administration
system) data.
doi: 10.1371/journal.pone.0079641.t003
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mellitus, osteoarthritis, osteoporosis, and COPD. Contradicting
life-style recommendations were found for osteoporosis and
diabetes mellitus.. As it is reasonable that our identified
disease pairs are highly common in (elderly) adults, it would be
useful if guidelines address potential drug interactions and
contradicting treatment recommendations (drug-disease
interactions, and disease-disease interactions) for these
disease pairs.
This systematic review has some limitations. We used the
term multimorbidity in our search process. This term is not well
indexed in literature databases, and we might have missed
some studies. To compensate for this constraint, we combined
an extended list of text words referring to the term
multimorbidity and we included the term comorbidity (with its
possible spelling variations) to our search strategy. Next, we
developed a scoring method based on several items of the
STROBE checklist[28], and added these items to our strict
inclusion and exclusion criteria, in order to obtain a minimal
quality standard of all included studies. As a result, we could
not differentiate further between levels of quality. Last, with this
type of study we were restricted to merely describe the most
frequently explored disease pairs in patients with
multimorbidity, and not necessarily the most occurring disease
pairs. Yet, the 12 identified diseases do represent highly
prevalent diseases internationally[56,57], and the
accompanying combinations of these diseases are also likely
to be highly prevalent.
Reflecting on our findings and limitations, more effort should
be made to establish a multimorbidity disease list with
uniformly defined diseases. Only by doing so, heterogeneity
between study results can be diminished, and information
about the prevalence and burden of multimorbidity will be more
genuine and comparable. It seems also important to have a
better understanding of specific treatment conflicts concerning
certain disease clusters, and not merely by scrutinizing the
existing guidelines, but by actually assessing daily practice
according to guideline recommendations. In this regard, it
seems practical to start with the most frequently occurring
diseases. Furthermore, it is still valuable to gain more insight
into (the prevalence of) specific co-occurring disease clusters,
especially of clusters of three, and four diseases, as a large
proportion of the elderly population is diagnosed with more
than two chronic conditions[50]. For the development of a
multimorbidity guideline, however, it might be easier to take
into account rather small disease clusters instead of broad,
comprehensive disease clusters[25,26].
Conclusion
Management of care for (older) patients with multimorbidity
can be challenging, or even burdensome. To be more
concrete, health professionals need to strike a balance
between the various disease-specific guidelines before one can
develop an appropriate treatment plan with feasible
recommendations and advices, taking the patient’s personal
abilities into account. The disease clusters that we have
distinguished, could serve as a first priority setting towards the
development of multimorbidity guidelines. A likely option is to
start with the most frequently occurring disease combinations,
as regards the evaluation of potential treatment conflicts, the
adjustment of existing clinical guidelines, or even the
development of new guidelines.
Table 4. Prevalence of clusters of two diseases, including an index-disease.
Index-disease Clustered with
Prevalence per study (%; %; %), data gathered by an
interview/survey*
Prevalence per study (%; %; %), data collected by
patients’ EMRs* No. of study*
Depression Hypertension 57.9  15
 Arthritis 55.6  15
 Diabetes Mellitus 23.2  15
 COPD/Asthma 23.3  15
 Cancer 10.9  15
 Heart disease 27.6  15
Hypertension Depression  16.7 17
Diabetes Mellitus Stroke  2.9 16
 Depression  3.9; 17.6 16, 17
 Cancer  2.7 16
Dementia Hypertension 37.1  11
 Stroke 16.4  11
Osteoarthritis Hypertension 19.8  10
Heart disease Depression  16.6 17
Prevalence of disease clusters found in at least three studies
EMR: Electronic medical record
* Not bold: studies conducted in a primary care setting, bold: studies conducted in the general population, italics: study based on VHA (Veterans Health Administration
system) data.
doi: 10.1371/journal.pone.0079641.t004
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